News
NMTC
0.6600
-4.01%
-0.0276
Weekly Report: what happened at NMTC last week (0609-0613)?
Weekly Report · 5d ago
Weekly Report: what happened at NMTC last week (0602-0606)?
Weekly Report · 06/09 10:28
NeuroOne Medical Technologies Corporation Appoints Emily Johns as General Counsel and Corporate Secretary
NASDAQ · 06/03 12:42
NeuroOne Medical appoints Johns as General Counsel, Corporate Secretary
TipRanks · 06/03 12:40
NEUROONE STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF EMILY JOHNS AS GENERAL COUNSEL AND CORPORATE SECRETARY
Reuters · 06/03 12:30
Weekly Report: what happened at NMTC last week (0526-0530)?
Weekly Report · 06/02 10:33
NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
Barchart · 05/29 12:05
Weekly Report: what happened at NMTC last week (0519-0523)?
Weekly Report · 05/26 10:33
Weekly Report: what happened at NMTC last week (0512-0516)?
Weekly Report · 05/19 10:26
NeuroOne Reports Strong Q2 2025 Financial Performance
TipRanks · 05/14 04:15
NeuroOne expects FY25 revenue to reach $8M–$10M as OneRF platform advances and new FDA submission broadens pipeline
Seeking Alpha · 05/13 13:46
NeuroOne Advances with FDA Submission and Capital Raise
TipRanks · 05/13 12:47
NeuroOne Medical Tech Affirms FY2025 Product Revenue Guidance of $8.00M-$10.00M
Benzinga · 05/13 12:15
NeuroOne Medical Technologies GAAP EPS of -$0.07
Seeking Alpha · 05/13 11:58
NeuroOne Medical reports Q2 EPS (7c) vs (11c) last year
TipRanks · 05/13 11:41
NeuroOne Medical Tech Q2 EPS $(0.07) Up From $(0.11) YoY, Sales $1.39M Beat $1.27M Estimate
Benzinga · 05/13 11:31
*NeuroOne Medical Tech: Fully Funded Through at Least FY26 >NMTC
Dow Jones · 05/13 11:31
NEUROONE® REPORTS SECOND QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS; GROSS MARGIN IMPROVES SIGNIFICANTLY YOY TO 55.6%
Reuters · 05/13 11:30
NEUROONE MEDICAL TECHNOLOGIES CORP: Q2 SHR LOSS $0.07
Reuters · 05/13 11:30
NEUROONE MEDICAL TECHNOLOGIES CORP - REAFFIRMS FY 2025 PRODUCT REVENUE GUIDANCE OF $8-$10 MLN
Reuters · 05/13 11:30
More
Webull provides a variety of real-time NMTC stock news. You can receive the latest news about Neuroone Med Technologies Corp through multiple platforms. This information may help you make smarter investment decisions.
About NMTC
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.